Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,316 | 135,821 | 135,029 | 52,071 | 61,031 |
| Marketable Securities | 272,327 | 252,443 | 331,830 | 380,742 | 306,709 |
| Receivables | 47,101 | 34,155 | 33,512 | 32,467 | 30,036 |
| Inventories | 1,726 | 1,357 | 1,194 | 1,025 | 1,280 |
| TOTAL | $438,890 | $432,946 | $519,292 | $478,301 | $409,145 |
| Non-Current Assets | |||||
| PPE Net | 2,132 | 2,037 | 2,573 | 3,113 | 4,136 |
| Intangibles | 114,096 | 121,369 | 18,565 | 20,081 | 21,559 |
| Other Non-Current Assets | 101,086 | 92,088 | 93,817 | 92,297 | 98,616 |
| TOTAL | $217,314 | $215,494 | $114,955 | $115,491 | $124,311 |
| Total Assets | $656,204 | $648,440 | $634,247 | $593,792 | $533,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,086 | 38,460 | 45,551 | 34,438 | 31,509 |
| Other current liabilities | 60,895 | 49,237 | 45,885 | 39,981 | N/A |
| TOTAL | $99,981 | $87,697 | $91,436 | $74,419 | $65,936 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 34,427 |
| Other Non-Current Liabilities | 14,531 | 15,833 | 15,613 | 14,445 | 14,254 |
| TOTAL | $17,677 | $15,833 | $15,613 | $14,445 | $14,254 |
| Total Liabilities | $117,658 | $103,530 | $107,049 | $88,864 | $80,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,316 | 57,538 | 56,785 | 55,907 | 54,883 |
| Common Shares | 58 | 58 | 57 | 56 | 55 |
| Retained earnings | -174,292 | -155,392 | -157,901 | -164,176 | -197,328 |
| Other shareholders' equity | 74 | -30 | -1,193 | -175 | 239 |
| TOTAL | $538,546 | $544,910 | $527,198 | $504,928 | $453,266 |
| Total Liabilities And Equity | $656,204 | $648,440 | $634,247 | $593,792 | $533,456 |